Montauk Renewables Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth Amid ...
| OSTX Stock | 3.97 0.06 1.53% |
Slightly above 54% of OS Therapies' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding OS Therapies Incorporated suggests that some traders are interested. OS Therapies' investing sentiment can be driven by a variety of factors including economic data, OS Therapies' earnings reports, geopolitical events, and overall market trends.
OSTX |
Release Date November 12, 2024For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Montauk Rene
Read at gurufocus.com
 |
OS Therapies Fundamental Analysis
We analyze OS Therapies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OS Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OS Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
OS Therapies is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
OS Therapies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OS Therapies stock to make a market-neutral strategy. Peer analysis of OS Therapies could also be used in its relative valuation, which is a method of valuing OS Therapies by comparing valuation metrics with similar companies.
Peers
OS Therapies Related Equities
| ZDGE | Zedge | 9.77 | ||||
| SPHR | Sphere Entertainment | 5.19 | ||||
| ATEX | Anterix | 2.95 | ||||
| RDCM | Radcom | 2.50 | ||||
| IRDM | Iridium Communications | 0.92 | ||||
| MNTK | Montauk Renewables | 0.54 | ||||
| DGII | Digi International | 4.68 |
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.